Indicators and significance of severity in influenza patients

International Congress Series

Volumn 1219, Issue C, 2001, Pages 637-643

  Fleming, D M ^a   Moult, A B ^b   Keene, O ^b  

^a Northfield Health Centre   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Age; Alleviation; Symptom; Temperature; Zanamivir

Indexed keywords

EID: 0013462994     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00373-9     Document Type: Article

References (4)

1. A.S. Monto, S. Gravenstein, M. Elliott, M. Colopy, J. Schweinle, Clinical signs and symptoms predicting influenza infection, Arch. Intern. Med., in press.
2. Monto, A.S., Webster, A., Keene, O., Randomized, placebo controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J. Antimicrob. Chemother. 44:Topic B (1999), 23–29.
3. A. Osterhaus, J. Hedrick, K. Henrickson, M. Mäkelä, A. Webster, O. Keene, Clinical efficacy of inhaled zanamivir for the treatment of influenza B: a pooled analysis of randomized, placebo-controlled studies, Clin. Drug Invest., in press.
4. Gravenstein, S., Freund, B., McElhaney, J., Schilling, M., et al. Greater effectiveness from zanamivir treatment of influenza with antecedent influenza vaccination in older adults., World Organisation of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians (WONCA), Vienna, Austria, July 2nd–6th, 2000 Abstract 114.